Synox Therapeutics Ltd.

ACTIVE

Irelandwww.synoxtherapeutics.comHolding1–10 employeesEstablished: 2020-01-01

Clinical Trials

4 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2020

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

80.0%

Phase 3

20.0%

Trial Status Distribution

Active, not recruiting

80.0%

Withdrawn

20.0%

Clinical Trials

Trials sponsored by this organization (5)

A Phase III, Multicentre, Randomised, Double-Blind Study to Assess the Safety and Efficacy of Emactuzumab vs. Placebo in Subjects with Tenosynovial Giant Cell Tumour.

A Trial to Assess the Safety and Efficacy of Emactuzumab versus Placebo in Patients with Giant Cell Tumours.

Phase 1

Active, not recruiting

interventional

Jun 2022160 participants

A Trial to Assess the Safety and Efficacy of Emactuzumab versus Placebo in Patients with Giant Cell Tumours.

Phase 1

Active, not recruiting

interventional

Jun 2022160 participants

A Trial to Assess the Safety and Efficacy of Emactuzumab versus Placebo in Patients with Giant Cell Tumours.

Phase 1

Active, not recruiting

interventional

May 2022160 participants

A Trial to Assess the Safety and Efficacy of Emactuzumab versus Placebo in Patients with Giant Cell Tumours.

Phase 1

Active, not recruiting

interventional

Mar 2022160 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations